Is Type 2 Diabetes Reversible? New Research Challenges Medical Consensus Introduction The concept of type 2 diabetes reversibility represents a profound shift in the understanding and management of a condition long regarded as chronic and progressive. Diabetes remains a major global health burden, with prevalence
Author: Nancy Ogbonna
Long COVID and the Brain: Decoding Post-Viral Neuroinflammation
Long COVID and the Brain: Decoding Post-Viral Neuroinflammation Abstract Long COVID has emerged as a significant and evolving global health challenge, affecting millions of individuals following acute infection with SARS-CoV-2. While respiratory and systemic symptoms were initially the primary focus of clinical attention, it has
The Internist’s Role in the Longevity Movement: Separating Science from Pseudoscience
The Internist’s Role in the Longevity Movement Separating Science from Pseudoscience Abstract The longevity movement has gained considerable traction in recent years, driven by advances in molecular biology, increased public interest in healthy aging, and widespread media coverage of anti-aging interventions. Promises of extended lifespan
The Role of the Gut Microbiome in Neurological Disorders
The Role of the Gut Microbiome in Neurological Disorders Abstract The gut microbiome has emerged as a central component in the evolving understanding of neurological health and disease. Advances in molecular biology, metagenomics, and neuroimmunology have revealed that the intestinal microbial ecosystem plays a significant role
The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy?
The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy? Abstract The development of tirzepatide, a first in class dual glucose dependent insulinotropic polypeptide and glucagon like peptide 1 receptor agonist, represents a potentially transformative advance in the management of type 2 diabetes and obesity. By simultaneously targeting
Why Tau Antibody Trials Failed in Alzheimer’s: New Evidence Reveals Critical Gaps
Why Tau Antibody Trials Failed in Alzheimer’s New Evidence Reveals Critical Gaps Introduction Tau directed antibody therapies represent one of the most scientifically compelling yet clinically challenging areas in the treatment of Alzheimer’s disease. Alzheimer’s disease is a progressive neurodegenerative disorder whose prevalence doubles approximately
The Silent Threat: Awareness Under Anesthesia in the Age of Light Sedation
The Silent Threat Awareness Under Anesthesia in the Age of Light Sedation Abstract Purpose This paper examines the phenomenon of awareness under anesthesia, with particular emphasis on its increased risk in the contemporary use of light anesthesia and sedation techniques. As anesthetic practice evolves toward lower drug
Skyrocketing Cancer Drug Prices: Can Oncologists Influence Policy?
Skyrocketing Cancer Drug Prices Can Oncologists Influence Policy Abstract The rapid escalation of cancer drug prices has emerged as a major challenge in contemporary oncology practice, with many newly approved therapies carrying annual costs that exceed one hundred thousand dollars per patient. This
The “Code Sepsis” Fatigue: When Protocols Collide with Clinical Judgment
The “Code Sepsis” Fatigue: When Protocols Collide with Clinical Judgment Abstract The global adoption of standardized sepsis protocols has been a central strategy in improving outcomes for patients with suspected or confirmed sepsis. Initiatives such as early warning systems, sepsis bundles, and time based
The Endocrine Disruptor Epidemic: What Should Clinicians Be Telling Patients?
The Endocrine Disruptor Epidemic: What Should Clinicians Be Telling Patients? Abstract Endocrine disrupting chemicals represent a growing public health concern that requires heightened awareness and engagement from healthcare professionals across disciplines. These substances, which include both synthetic and naturally occurring compounds, have the capacity
